Tarsus Pharmaceuticals (TARS) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Q3 2025 value amounting to -$0.3.
- Tarsus Pharmaceuticals' EPS (Weighted Average and Diluted) rose 5081.97% to -$0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.01, marking a year-over-year increase of 4668.44%. This contributed to the annual value of -$3.07 for FY2024, which is 3348.76% up from last year.
- According to the latest figures from Q3 2025, Tarsus Pharmaceuticals' EPS (Weighted Average and Diluted) is -$0.3, which was up 5081.97% from -$0.48 recorded in Q2 2025.
- Tarsus Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $0.47 for Q1 2021, and its period low was -$1.28 during Q3 2023.
- In the last 5 years, Tarsus Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.7 in 2021 and averaged -$0.65.
- Per our database at Business Quant, Tarsus Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 16351.35% in 2021 and then plummeted by 38750.0% in 2023.
- Over the past 5 years, Tarsus Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.7 in 2021, then surged by 30.49% to -$0.49 in 2022, then crashed by 159.18% to -$1.27 in 2023, then soared by 51.66% to -$0.61 in 2024, then soared by 51.13% to -$0.3 in 2025.
- Its last three reported values are -$0.3 in Q3 2025, -$0.48 for Q2 2025, and -$0.64 during Q1 2025.